Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae.
about
Mucormycosis, pseudallescheriasis, and other uncommon mold infectionsRecent advances in the management of mucormycosis: from bench to bedsideNLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised LearningCorrelation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice.Recent advances in the treatment of mucormycosis.Human Fungal Pathogens of Mucorales and Entomophthorales.Antifungal pharmacokinetics and pharmacodynamicsCombination therapy for mucormycosis: why, what, and how?Gastrointestinal Mucormycosis following a Streptococcus pyogenes Toxic Shock Syndrome in a Previously Healthy Patient: A Case Report.Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.Rhino-orbital-cerebral mucormycosis.Multimodal surgical and medical treatment for extensive rhinocerebral mucormycosis in an elderly diabetic patient: a case report and literature review.Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs.Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014.Combination therapy for the treatment of pulmonary mold infections.Invasive mold infections: virulence and pathogenesis of mucorales.Correlation of in vitro activity, serum levels, and in vivo efficacy of posaconazole against Rhizopus microsporus in a murine disseminated infection.Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice.Posaconazole mono- or combination therapy for treatment of murine zygomycosis.Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries.Use of posaconazole in the treatment of infective rhinocerebral mucormycosis.ABC transporters coupled with the elevated ergosterol contents contribute to the azole resistance and amphotericin B susceptibility.
P2860
Q24603297-4FF477CA-1DE7-4397-AD37-65E6D1D422C3Q24642450-0D260B3E-C6F4-4C48-94FB-C11FCA0F2B01Q28552626-FB79996B-2A21-429B-9247-543BE7102222Q33826450-6C898896-BB12-45A5-A8FF-5A091F4C4194Q34161213-E0CEB032-9A00-4C16-9054-7F0611C37064Q35245238-FBE1CE15-7D40-44EC-AFD0-25545D7F5A5BQ35663841-4D881742-49A4-4EAE-8CE8-BA0C95AC2B19Q35974333-D84D7158-7761-400C-A089-5789FCF4AA18Q36147953-19943FB5-22FF-44A5-8CC1-D833E08C43ABQ36862446-79332A35-3E40-4060-920B-7602D5842937Q36969836-A02DD199-2302-47FD-8C63-4EB0CEBC0293Q37041199-DE09268A-E226-4D8A-8FCF-673139A67430Q37404840-E2D25207-60DE-4416-8BBE-709A977D37F5Q38017577-72395A22-0EC9-4882-A940-7F9E13EE303DQ38225122-ABA9E72A-524C-46D6-994A-7EA134D8761CQ38245046-3D5BC861-EC3B-42C4-BDBA-CF26B53772DBQ38284463-FA62AA07-FD64-4015-B8E8-59417475E123Q38806932-EF75868B-36F6-4600-BDB5-2CD138F221C2Q38909410-EF4CEFBC-BBA2-4501-8DD2-DEEB93453AB1Q41850557-5F5FDDD8-C7CC-4D88-8858-45F4C7FFEDB6Q42095363-FA4302D3-13E1-402C-9FF7-A222DC4F80AAQ42183489-380A46E2-8073-4FAC-BC52-7FD6F2964DB4Q42958723-0CE181D7-FE45-4F9C-B328-A83CA1772CB7Q43101266-45934193-1072-4CC8-985C-448A6965690DQ47609964-B8CCB7D8-B86E-482B-AA25-A2F65293E3E0
P2860
Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Posaconazole combined with amp ...... ion caused by Rhizopus oryzae.
@en
Posaconazole combined with amp ...... ion caused by Rhizopus oryzae.
@nl
type
label
Posaconazole combined with amp ...... ion caused by Rhizopus oryzae.
@en
Posaconazole combined with amp ...... ion caused by Rhizopus oryzae.
@nl
prefLabel
Posaconazole combined with amp ...... ion caused by Rhizopus oryzae.
@en
Posaconazole combined with amp ...... ion caused by Rhizopus oryzae.
@nl
P2093
P2860
P356
P1476
Posaconazole combined with amp ...... tion caused by Rhizopus oryzae
@en
P2093
F Javier Pastor
M Mar Rodríguez
Marçal Mariné
P2860
P304
P356
10.1128/AAC.00628-08
P407
P577
2008-08-11T00:00:00Z